Dr. AlShehhi was trained and lived in Ireland between 1987 till 2005. He graduate from the RCSI in 1995, he then finished rheumatology training in 2005 in Saint Vincent’s Hospital Ireland. He was then a consultant rheumatologist in Zayed Military hospital until Jan 2007. In addition, he was also consultant rheumatologist in AlQassimi hospital Sharjah and Saif hospital RasAlKhaimah untill Sept 2010 (public sector).
Currently, Dr. AlShehhi is a Consultant rheumatologist in Dr. Sulaiman AlHabib (private) Medical Centre Dubai health care city since 2009 to date. Dr. AlShehhi is an accredited EULAR trainer in musculoskeletal ultrasound and an Examiner for the RCPI- Ireland. He also worked as a lecturer in Sharjah Medical University. He is the Founder and current President of the Emirates society for rheumatology (ESR) and the Chairman for the Asia Pacific League against rheumatism (APLAR) in Dubai 2017. He is a fellow of the American college for rheumatology.
Dr. AlShehhi, father of 6, has chaired and presented at over 200 different national, regional and international rheumatology meetings. He has been awarded the best Physician in UAE (private sector 2014). He has a number of publications in both RA and PsA. His main area of interest is Spondyloarthritis, Biosimilars and MSK- US.
Assessment of clinical efficacy and safety in a randomized double blind study of Etanercept and Sulfasalazine in patients with Ankylosing spondylitis from Eastern/ Central Europe, Latin America and Asia. May 2016, Vol 36, pp 643- 651.